Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-01-08

FDA Approved: SACUBITRIL AND VALSARTAN — Original Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Lupin Pharmaceuticals' original application for a generic sacubitril/valsartan product, enabling access to this heart failure therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sacubitril and valsartan (sacubitril/valsartan)

Snippet

ORIG AP for SACUBITRIL AND VALSARTAN (SACUBITRIL AND VALSARTAN)